As of 2025-05-09, the Intrinsic Value of Organon & Co (OGN) is 68.10 USD. This OGN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 9.02 USD, the upside of Organon & Co is 655.00%.
The range of the Intrinsic Value is 46.08 - 109.53 USD
Based on its market price of 9.02 USD and our intrinsic valuation, Organon & Co (OGN) is undervalued by 655.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 46.08 - 109.53 | 68.10 | 655.0% |
| DCF (Growth 10y) | 53.89 - 119.54 | 76.77 | 751.1% |
| DCF (EBITDA 5y) | 29.00 - 52.80 | 37.48 | 315.5% |
| DCF (EBITDA 10y) | 39.88 - 67.94 | 50.31 | 457.7% |
| Fair Value | 16.62 - 16.62 | 16.62 | 84.23% |
| P/E | 47.19 - 58.23 | 52.92 | 486.7% |
| EV/EBITDA | 24.91 - 80.96 | 42.88 | 375.4% |
| EPV | 38.31 - 70.26 | 54.28 | 501.8% |
| DDM - Stable | 19.97 - 42.10 | 31.04 | 244.1% |
| DDM - Multi | 18.41 - 30.63 | 23.03 | 155.4% |
| Market Cap (mil) | 2,344.84 |
| Beta | 0.35 |
| Outstanding shares (mil) | 259.96 |
| Enterprise Value (mil) | 10,549.84 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.88% |
| Cost of Debt | 5.04% |
| WACC | 5.43% |